最高の卵巣癌医師 - トップ117名の医師

Prof. Dr. Bülent Karagöz は、アナドル医療センターにて腫瘍生物学と免疫療法を専門とし、33年の経験 の医療腫瘍学の経験を持つ卵巣癌の専門家です。

• 権威あるGATA Haydarpaşa研修病院における腫瘍内科部長
• がん研究分野における40本以上の論文著者
• イスタンブール・オカン大学医学部教授
• トルコ腫瘍内科学会会員

エダ・タンリクル医師は、アナドル医療センターにて腫瘍内科および化学療法を専門とし、卵巣癌の治療に注力しています。

• マルマラ大学にて腫瘍内科の研修を修了
• 腫瘍学における国際臨床試験を主導
• 癌症例に関する多職種レビューチームに参加
• ハイダルパシャ・ヌムネ研修研究病院にて腫瘍内科部長を歴任

900件以上の手術実績 – ヤルチンカヤ医師は、アナドル医療センターにおける婦人科腫瘍学の専門家です。

• 婦人科および婦人科腫瘍学における20年の経験年の診療経験
• 卵巣癌症例を専門とする准教授
• 包括的な医療提供のための多職種腫瘍チームに所属
• ケアの質に関する患者評価：4.6

ハジェテペ大学癌研究所にてフェローシップを修了 – Solak医師は卵巣癌の診断と治療を専門としています。

• テキサス大学MDアンダーソン癌センターにて研修を修了
• 卵巣癌の複雑な症例を担当
• イスタンブール・シシュリ・エトファル研修研究病院にて研修医課程を修了
• ハジェテペ大学同窓会ネットワークの会員

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

卵巣癌を専門とする認定外科腫瘍医であり、メキシコの腫瘍学水準の向上を目指すSMEOの会員です。

• 外科腫瘍医として6年の経験の経験
• 2020年よりアナワク大学にて大学講師を務める
• Conacemによる2030年までの専門医認定取得
• ガレニア病院にて卵巣癌手術を実施

Specialist in Oncological Gynecology and Radiotherapy

卵巣癌の第一人者であり、肉腫および骨腫瘍学に深い専門知識を持つメリムスキー博士は、スーラスキー医療センターの腫瘍科外来クリニックを統括しています。

• 腫瘍学における41年の経験以上の経験を有し、複雑な症例を専門とする
• 軟部組織・骨腫瘍ユニット長
• ワイツマン科学研究所およびフェルセンスタイン医学研究センター上席研究員
• ESMO軟部組織・骨肉腫ファカルティメンバー
• 癌の研究と治療に関する論文を多数発表

Cem Iyibozkurt教授は、イスタンブール・フローレンス・ナイチンゲール病院において、卵巣癌に対する低侵襲手術およびロボット手術を専門としています。

• 婦人科腫瘍学における31年の経験年以上の経験
• フロリダ病院（オーランド）にてロボット手術の研修を修了
• イスタンブール大学にて分子医学の博士号取得
• 欧州婦人科腫瘍学会会員

Dr. Altay Aliyev is a clinical oncologist at Liv Bona Dea Hospital Baku. He specializes in chemotherapy, immunotherapy, and targeted treatments for various cancers. Dr. Aliyev completed a fellowship as a research associate at the Cleveland Clinic. He treats complex conditions like glioblastoma, metastatic breast cancer, and colorectal tumors.

• Expertise covers cytotoxic chemotherapy, hormone therapy, and palliative oncological care.
• Published research on tumor markers in thyroid cancer and breast cancer chemotherapy.
• Formerly served as a research associate in the Cleveland Clinic Endocrinology Department.
• Practices at Liv Bona Dea Hospital, a JCI-accredited facility in Azerbaijan.

メフメット・カラジャ教授は、メディカルパーク・アンタルヤ病院複合施設において、高度な腹腔鏡技術を用いた婦人科がんを専門としています。

• 産科・婦人科における31年の経験年以上の診療経験
• 保健省による婦人科腫瘍外科の専門研修修了
• ハイリスク妊娠および骨盤底機能障害（女性骨盤底医学）における専門的知識
• 産科・婦人科学博士号取得

Dr. Rana Niftaliyeva is an oncologist-mammologist at the Biological Medicine Integrative Health Center in Baku. She specializes in breast cancer treatment and precancerous mammary gland diseases. Dr. Niftaliyeva has participated in medical conferences across Azerbaijan, Germany, and Turkey. She focuses on integrative approaches to cancer care.

• Treats large breast cysts using non-surgical aspiration techniques.
• Provides mistletoe therapy and high-dose vitamin C cancer treatments.
• Manages side effects of chemotherapy and radiation through supportive care.
• Performs biopsies and hormonal therapy for various oncological conditions.

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology